
The products available on this website are intended exclusively for research and professional use. They are not approved by the FDA for human consumption, diagnosis, treatment, or prevention of any disease.
By entering this site, you confirm that you are a qualified researcher, licensed professional, or otherwise authorized to purchase research-grade compounds, and that you will use these products solely for lawful research purposes.
This notice is displayed in compliance with applicable regulations governing the sale of research compounds. Human Upgrade Labs does not condone or encourage the misuse of any research products.
Your cart is empty

TrinityGLP is a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has shown significant potential in metabolic research, with studies demonstrating substantial effects on body weight and metabolic parameters.
Lyophilized: -20°C. Reconstituted: 2–8°C.

NNMT inhibitor for metabolic optimization and fat cell reduction research.

Modified GH fragment targeting fat metabolism without affecting IGF-1 levels.

Long-acting amylin analog for appetite regulation and metabolic research.
FOR RESEARCH PURPOSES ONLY · NOT FOR HUMAN OR ANIMAL CONSUMPTION · NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE